A Crossover Study in the Treatment of Patients With COPD
Public ClinicalTrials.gov record NCT00462540. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to compare the efficacy of Formoterol Fumarate Inhalation Solution (FFIS) 20 mcg BID to Combivent® Inhalation Aerosol \[2 inhalations from metered dose inhaler (MDI)of 18 mcg ipratropium bromide and 103 mcg albuterol sulfate QID\], and to Compare the preference/compliance of BID nebulization to QID use of MDI
Study identification
- NCT ID
- NCT00462540
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 100 participants
Conditions and interventions
Conditions
Interventions
- Formoterol Fumurate inhalation solution 20 mcg Drug
- Ipratropium bromide 18 mcg and albuterol sulfate 103 mcg Drug
Drug
Eligibility (public fields only)
- Age range
- 40 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2007 (Type not available)
- Primary completion
- Sep 2007 (Actual)
- Completion
- Oct 2007 (Actual)
- Last update posted
- Mar 4, 2009
2007
United States locations
- U.S. sites
- 15
- U.S. states
- 12
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | San Diego | California | 92120 | — |
| Research Site | Denver | Colorado | 80206 | — |
| Research Site | Wheat Ridge | Colorado | 80033 | — |
| Research Site | Panama City | Florida | 32405 | — |
| Research Site | Pensacola | Florida | 32504 | — |
| Research Site | Coeur d'Alene | Idaho | 83814 | — |
| Research Site | Sunset | Louisiana | 70584 | — |
| Research Site | Charlotte | North Carolina | 28207 | — |
| Research Site | Portland | Oregon | 97213 | — |
| Research Site | Gaffney | South Carolina | 29340 | — |
| Research Site | Spartanburg | South Carolina | 29303 | — |
| Research Site | Johnson City | Tennessee | 37601 | — |
| Research Site | San Antonio | Texas | 78205 | — |
| Research Site | Spokane | Washington | 99204 | — |
| Research Site | Morgantown | West Virginia | 26505 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00462540, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 4, 2009 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00462540 live on ClinicalTrials.gov.